Literature DB >> 33750322

A novel variant in the COL6A1 gene causing Ullrich congenital muscular dystrophy in a consanguineous family: a case report.

Nirmala Dushyanthi Sirisena1, U M Jayami Eshana Samaranayake2, Osorio Lopes Abath Neto3, A Reghan Foley3, B A P Sajeewani Pathirana2, Nilaksha Neththikumara2, C Sampath Paththinige2,4, Pyara Rathnayake5, Sandra Donkervoort3, Carsten G Bönnemann3, Vajira H W Dissanayake2.   

Abstract

BACKGROUND: Collagen VI-related dystrophies are a subtype of congenital muscular dystrophy caused by pathogenic variants in COL6A1, COL6A2 or COL6A3 genes affecting skeletal muscles and connective tissue. The clinical phenotype ranges from the milder Bethlem myopathy to the severe Ullrich congenital muscular dystrophy (UCMD). Herein, we report the first consanguineous Sri Lankan family with two children affected with UCMD due to a novel variant in the COL6A1 gene. CASE
PRESENTATION: Two sisters, aged 10-years and 7-years, presented with progressive, bilateral proximal muscle weakness. Both probands had delayed motor milestones and demonstrated difficulty in standing from a squatting position, climbing stairs and raising arms above the shoulders. Cognitive, language and social development were age appropriate. Examination showed proximal muscle weakness of the upper and lower extremities and hyperlaxity of the wrist and fingers in both with some variability in clinical severity noted between the two siblings. Serum creatine kinase levels were elevated, and electromyography showed low polyphasic motor unit potentials in the 10-year-old and myopathic features with short duration motor unit potentials with no polyphasia in the 7-year-old. Whole exome sequencing (WES) was performed and a novel, homozygous missense, likely pathogenic variant in exon 25 of COL6A1 gene [NM_001848: c.1667G > T;NP_001839.2:p.Gly556Val] was identified in both probands. This variant was validated by Sanger sequencing in proband 1 as well as proband 2, and the parents and an unaffected sibling were found to be heterozygote carriers for the same variant.
CONCLUSIONS: The findings in this family add to the expanding number of COL6A1 variants identified and provides a better understanding of the genotype-phenotype correlations associated with UCMD.

Entities:  

Keywords:  COL6A1; Case report; Collagen type VI; Consanguineous; Myopathy; Phenotypic heterogeneity; Ullrich congenital muscular dystrophy

Mesh:

Substances:

Year:  2021        PMID: 33750322      PMCID: PMC7941924          DOI: 10.1186/s12883-021-02134-7

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  14 in total

1.  Early onset collagen VI myopathies: Genetic and clinical correlations.

Authors:  Laura Briñas; Pascale Richard; Susana Quijano-Roy; Corine Gartioux; Céline Ledeuil; Emmanuelle Lacène; Samira Makri; Ana Ferreiro; Svetlana Maugenre; Haluk Topaloglu; Göknur Haliloglu; Isabelle Pénisson-Besnier; Pierre-Yves Jeannet; Luciano Merlini; Carmen Navarro; Annick Toutain; Denys Chaigne; Isabelle Desguerre; Christine de Die-Smulders; Murielle Dunand; Bernard Echenne; Bruno Eymard; Thierry Kuntzer; Kim Maincent; Michèle Mayer; Ghislaine Plessis; François Rivier; Filip Roelens; Tanya Stojkovic; Ana Lía Taratuto; Fabiana Lubieniecki; Soledad Monges; Christine Tranchant; Louis Viollet; Norma B Romero; Brigitte Estournet; Pascale Guicheney; Valérie Allamand
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

2.  Ullrich Congenital Muscular Dystrophy Possibly Related With COL6A1 p.Gly302Arg Variant.

Authors:  Yoonhong Park; Myung Seok Park; Duk Hyun Sung; Ji Yeon Sohn; Chang-Seok Ki; Du-Hwan Kim
Journal:  Ann Rehabil Med       Date:  2014-04-29

3.  Natural history of Ullrich congenital muscular dystrophy.

Authors:  A Nadeau; M Kinali; M Main; C Jimenez-Mallebrera; A Aloysius; E Clement; B North; A Y Manzur; S A Robb; E Mercuri; F Muntoni
Journal:  Neurology       Date:  2009-07-07       Impact factor: 9.910

4.  Bethlem myopathy: a slowly progressive congenital muscular dystrophy with contractures.

Authors:  G J Jöbsis; J M Boers; P G Barth; M de Visser
Journal:  Brain       Date:  1999-04       Impact factor: 13.501

5.  Dominant and recessive COL6A1 mutations in Ullrich scleroatonic muscular dystrophy.

Authors:  Betti Giusti; Laura Lucarini; Valentina Pietroni; Simona Lucioli; Brunella Bandinelli; Patrizia Sabatelli; Stefano Squarzoni; Stefania Petrini; Corine Gartioux; Beril Talim; Filip Roelens; Luciano Merlini; Haluk Topaloglu; Enrico Bertini; Pascale Guicheney; Guglielmina Pepe
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

6.  Frameshift mutation in the collagen VI gene causes Ullrich's disease.

Authors:  I Higuchi; T Shiraishi; T Hashiguchi; M Suehara; T Niiyama; M Nakagawa; K Arimura; I Maruyama; M Osame
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

7.  Autosomal recessive inheritance of classic Bethlem myopathy.

Authors:  A Reghan Foley; Ying Hu; Yaqun Zou; Alexandra Columbus; John Shoffner; Diane M Dunn; Robert B Weiss; Carsten G Bönnemann
Journal:  Neuromuscul Disord       Date:  2009-11-01       Impact factor: 4.296

8.  Nutritional status evaluation in patients affected by bethlem myopathy and ullrich congenital muscular dystrophy.

Authors:  Silvia Toni; Riccardo Morandi; Marcello Busacchi; Lucia Tardini; Luciano Merlini; Nino Carlo Battistini; Massimo Pellegrini
Journal:  Front Aging Neurosci       Date:  2014-11-17       Impact factor: 5.750

9.  Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report.

Authors:  Elena Martoni; Stefania Petrini; Cecilia Trabanelli; Patrizia Sabatelli; Anna Urciuolo; Rita Selvatici; Adele D'Amico; Sofia Falzarano; Enrico Bertini; Paolo Bonaldo; Alessandra Ferlini; Francesca Gualandi
Journal:  BMC Med Genet       Date:  2013-06-05       Impact factor: 2.103

10.  Ullrich Congenital Muscular Dystrophy (UCMD): Clinical and Genetic Correlations.

Authors:  Bita Bozorgmehr; Ariana Kariminejad; Shahriar Nafissi; Bita Jebelli; Urtizberea Andoni; Corine Gartioux; Celine Ledeuil; Valérie Allamand; Pascale Richard; Mohammad-Hassan Kariminejad
Journal:  Iran J Child Neurol       Date:  2013
View more
  1 in total

1.  COL6A6 inhibits the proliferation and metastasis of non-small cell lung cancer through the JAK signalling pathway.

Authors:  Han Qiao; Yan Feng; Huaping Tang
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.